Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01671163 · ClinicalTrials.gov registry record
Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiotherapy
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 18
- Enrollment target
NCT01671163: Clinical Trial study, sponsored by University of Florida.
NCT01671163 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01671163 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate placing the radiation therapy markers (Fiducial) by using an endoscopic procedure. The endoscopic procedure is called an Endoscopic Ultrasound (EUS). This is a procedure using a special endoscope that has an ultrasound on the end. The ultrasound will allow the doctor's to see where the radiation therapy markers (Fiducial) is to be placed as outlined by the Radiation Oncologist.
Primary Outcome
The outcome measure for this study is to determine: 1. The successful delivery, to the targeted tissue,of the fiducials through the fiducial delivery system, 2. The accuracy of the fiducial delivery into the targeted tissue and 3. to see if the fiducials can be visualized via Endoscopic Ultrasound (EUS), Fluoroscopy and/or CT scan. The success and accuracy of the delivery will be evaluated by Endoscopic Ultrasound, fluoroscopy and/or CT scan to determine if the fiducials are in the targeted ti
Interventions
- PROCEDURE Endoscopic Ultrasound (EUS) for fiducial placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2012-07 |
| Est. Completion | 2019-08-12 |
Why NCT01671163 stopped before completion
NCT01671163 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Endoscopic Ultrasound (EUS) for fiducial placement is the first listed.
NCT01671163 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01671163 about?
NCT01671163 is a clinical study titled "Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiotherapy". The purpose of this research study is to evaluate placing the radiation therapy markers (Fiducial) by using an endoscopic procedure. The endoscopic procedure is called an Endoscopic Ultrasound (EUS). This is a procedure using a special endoscope that has an ultrasound on the end. The ultrasound will...
What is the current status of trial NCT01671163?
This trial is currently terminated. The enrollment target is 18 participants. The study started on 2012-07. Estimated completion is 2019-08-12.
What interventions are being tested in trial NCT01671163?
The interventions under investigation include: Endoscopic Ultrasound (EUS) for fiducial placement (PROCEDURE).
Who is sponsoring clinical trial NCT01671163?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia